EcoDrugPlus

Neuronal Acetylcholine Receptor Subunit Alpha-7

Ensembl ID : ENSELUG00000022503
Gene Symbol: LOC105013919
3 Cross references
208 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSELUG00000008187
Gene Symbol: NPY2R
3 Cross references
178 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSELUG00000020999
Gene Symbol: NPY2R
3 Cross references
183 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSELUG00000009446
Gene Symbol: NTSR1
3 Cross references
200 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSELUG00000012483
Gene Symbol: NTRK1
3 Cross references
200 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSELUG00000002774
Gene Symbol: NTRK2
1 Cross references
210 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSELUG00000016689
Gene Symbol: NTRK3
3 Cross references
198 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSELUG00000010573
Gene Symbol: NTRK3
3 Cross references
157 Possible Orthologues:

Neurotrophic Tyrosine Kinase, Receptor, Type 2b

Ensembl ID : ENSELUG00000003955
Gene Symbol: NTRK2B
1 Cross references
213 Possible Orthologues:

Nicastrin

Ensembl ID : ENSELUG00000003766
Gene Symbol: NCSTN
4 Cross references
204 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSELUG00000007097
Gene Symbol: NAMPT
2 Cross references
158 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSELUG00000017244
Gene Symbol: NAMPT
3 Cross references
219 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).